Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Obesity treatments may offer powerful bonus benefit: Lowering high blood pressure Regina Schaffer
-
- Aldosterone: The hidden hormone linking hypertension and obesity, and a potential target Florian Rader, MD
- FDA clears automated insulin delivery system for children and adults with type 1 diabetes
- Future obesity treatment may see bariatric surgery combined with medication Michael Monostra
- Hybrid closed-loop system boosts time in range for pregnant women with type 1 diabetes Michael Monostra
- Medicare to cover semaglutide for CV prevention for adults with overweight and obesity Michael Monostra
- Monthly olezarsen reduced triglyceride levels by 50% Katie Kalvaitis
- ‘Monumental occasion’: FDA approves Madrigal’s Rezdiffra as first treatment for MASH Monica Stonehill
- Once-weekly basal insulin noninferior to once-daily insulin for type 1, type 2 diabetes Michael Monostra
-
- Q&A: People with diabetes can benefit from whole foods, plant-based eating plan Susan Weiner, MS, RDN, CDN, CDCES, FADCES; Lauren Plunkett, RDN, LD, CDCES
- Q&A: Standards of Care encourages more people with diabetes to use CGM Michael Monostra
- Team-based telehealth approach improves medication use in high-risk patients with diabetes Erik Swain; Scott Buzby
- VIDEO: Pamela S. Douglas, MD, highlights need for diversity in clinical trials leadership Pamela S. Douglas, MD, MACC, FASE, FAHA
- VIDEO: Sanjay Rajagopalan, MD, on building sustainable cities that embrace heart health Sanjay Rajagopalan, MD, MBA, FACC, FAHA
- Are drugs or surgery superior for obesity treatment?